blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3303348

EP3303348 - NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 26.07.2024
FormerThe patent has been granted
Status updated on  05.07.2019
FormerGrant of patent is intended
Status updated on  17.02.2019
FormerRequest for examination was made
Status updated on  09.03.2018
FormerThe international publication has been made
Status updated on  02.12.2016
Most recent event   Tooltip10.07.2020No opposition filed within time limitpublished on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Theravance Biopharma R&D IP, LLC
901 Gateway Boulevard
South San Francisco, CA 94080 / US
[2018/15]
Inventor(s)01 / HUDSON, Ryan
1454 Walbrook Drive
San Jose, California 95129 / US
02 / KOZAK, Jennifer
771 Prairie Creek Drive
Pacifica, California 94044 / US
03 / FATHEREE, Paul R.
921 Minnesota Street
San Francisco, California 94107 / US
04 / PODESTO, Dante D.
1122 Trinity Avenue
Modesto, California 95350 / US
05 / BRANDT, Gary E.L.
2160 Buena Vista Avenue
Alameda, California 94501 / US
06 / FLEURY, Melissa
47D Joy Avenue
Brisbane, California 94005 / US
07 / BEAUSOLEIL, Anne-Marie
600 Brewster Avenue, Apt. 306
Redwood City, California 94063 / US
08 / HUANG, Xiaojun
5978 Bollinger Road
San Jose, CA 95129 / US
09 / THALLADI, Venkat R.
888 Foster City Boulevard Apt. E3
Foster City, California 94404 / US
 [2019/32]
Former [2018/15]01 / HUDSON, Ryan
1454 Walbrook Drive
San Jose, California 95129 / US
02 / KOZAK, Jennifer
771 Prairie Creek Drive
Pacifica, California 94044 / US
03 / FATHEREE, Paul R.
921 Minnesota Street
San Francisco, California 94107 / US
04 / PODESTO, Dante D.
1122 Trinity Avenue
Modesto, California 95350 / US
05 / BRANDT, Gary E.L.
2160 Buena Vista Avenue
Alameda, California 94501 / US
06 / FLEURY, Melissa
47D Joy Avenue
Brisbane, California 94005 / US
07 / BEAUSOLEIL, Anne-Marie
600 Brewster Avenue, Apt. 306
Redwood City, California 94063 / US
08 / HUANG, Xiaojun
513 Granger Terrace
Sunnyvale, California 94087 / US
09 / THALLADI, Venkat R.
888 Foster City Boulevard Apt. E3
Foster City, California 94404 / US
Representative(s)Abel & Imray LLP
Westpoint Building
James Street West
Bath BA1 2DA / GB
[N/P]
Former [2018/15]Abel & Imray
Westpoint Building
James Street West
Bath BA1 2DA / GB
Application number, filing date16728495.926.05.2016
[2018/15]
WO2016US34243
Priority number, dateUS201562167694P28.05.2015         Original published format: US 201562167694 P
US201662312273P23.03.2016         Original published format: US 201662312273 P
[2018/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016191524
Date:01.12.2016
Language:EN
[2016/48]
Type: A1 Application with search report 
No.:EP3303348
Date:11.04.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 01.12.2016 takes the place of the publication of the European patent application.
[2018/15]
Type: B1 Patent specification 
No.:EP3303348
Date:07.08.2019
Language:EN
[2019/32]
Search report(s)International search report - published on:EP01.12.2016
ClassificationIPC:C07D519/00, A61K31/439, A61P1/04
[2018/15]
CPC:
C07D519/00 (EP,CN,IL,US); C07D471/06 (KR); A61K31/4375 (KR);
A61K31/46 (EP,IL,KR,US); A61K45/06 (IL,US); A61P1/00 (EP,IL);
A61P1/04 (EP,IL); A61P29/00 (EP,IL); A61P43/00 (EP,IL);
C07D401/14 (KR); C07D471/04 (KR); C07B2200/13 (IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/15]
Extension statesBA27.11.2017
ME27.11.2017
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NAPHTHYRIDIN- VERBINDUNGEN ALS JAK KINASE INHIBITOREN[2019/07]
English:NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS[2018/15]
French:COMPOSÉS DE NAPHTHYRIDINE EN TANT QU'INHIBITEURS DE KINASES JAK[[2019/07]
Former [2018/15]NAPHTHYRIDINVERBINDUNGEN ALS JAK-KINASE-INHIBITOREN
Former [2018/15]COMPOSÉS DE NAPHTYRIDINE EN TANT QU'INHIBITEURS DE LA KINASE JAK
Entry into regional phase27.11.2017National basic fee paid 
27.11.2017Designation fee(s) paid 
27.11.2017Examination fee paid 
Examination procedure27.11.2017Examination requested  [2018/15]
27.11.2017Date on which the examining division has become responsible
31.07.2018Amendment by applicant (claims and/or description)
18.02.2019Communication of intention to grant the patent
27.06.2019Fee for grant paid
27.06.2019Fee for publishing/printing paid
27.06.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19182836.7  / EP3569604
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
29.05.2018Renewal fee patent year 03
28.05.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2006067614  (PFIZER PROD INC [US], et al) [A] 1-33* the whole document *;
 [A]WO2007071348  (HOFFMANN LA ROCHE [CH], et al) [A] 1-33 * the whole document *;
 [A]WO2008119792  (PALAU PHARMA SA [ES], et al) [A] 1-33 * the whole document *
by applicant   - DANESE ET AL., N ENGL J MED, (2011), vol. 365, pages 1713 - 1725
    - ALLEZ ET AL., J CROHN'S COLITIS, (2010), vol. 4, pages 355 - 366
    - RUTGEERTS ET AL., NENGL J MED, (2005), vol. 353, pages 2462 - 2476
    - TARGOWNIK ET AL., AM J GASTROENTEROL, (2012), vol. 107, pages 1228 - 1235
    - STROBER ET AL., GASTROENTEROL, (2011), vol. 140, pages 1756 - 1767
    - CLARK ET AL., J MED CHEM, (2014), vol. 57, pages 5023 - 5038
    - T. W. GREENE; G. M. WUTS, Protecting Groups in Organic Synthesis, WILEY
    - REIMUND ET AL., J CLIN IMMUNOLOGY, (1996), vol. 16, pages 144 - 150
    - WOYWODT ET AL., EUR J GASTROENTEROLOGY HEPATOLOGY, (1999), vol. 11, pages 267 - 276
    - KUMAWAT ET AL., MOL IMMUNOLOGY, (2013), vol. 55, pages 355 - 364
    - WEINBRAND-GOICHBERG ET AL., IMMUNOL RES, (2013), vol. 56, pages 249 - 260
    - COGHILL ET AL., BLOOD, (2001), vol. 117, pages 3268 - 3276
    - STALLMACH ET AL., INT J COLORECTAL DIS, (2004), vol. 19, pages 308 - 315
    - ZHOU ET AL., AUTOIMMUN REV, (2012), vol. 11, pages 699 - 704
    - DENITTO ET AL., WORLD J GASTROENTEROL, (2009), vol. 15, pages 4609 - 4614
    - YANO ET AL., J TRANSLATION MED, (2014), vol. 12, page 191
    - YAMAMOTO ET AL., DIG LIVER DIS, (2008), vol. 40, pages 253 - 259
    - MOZAFFARI ET AL., EXPERT OPIN. BIOL. THER., (2014), vol. 14, pages 583 - 600
    - DANESE, GUT, (2012), vol. 61, pages 918 - 932
    - LAM ET AL., IMMUNOTHERAPY, (2014), vol. 6, pages 963 - 971
    - SHELDRICK, ACTA CRYST., (2015), vol. C71, pages 3 - 8
    - HELLER ET AL., IMMUNOLOGY, (2002), vol. 17, pages 629 - 638
    - KUDLACZ ET AL., AM. J. OF TRANSPLANTATION, (2004), vol. 4, pages 51 - 57
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.